XERS Earnings

Quarterly EPS
$-0.11
Q3 2024
$-0.03
Q4 2024
$-0.06
Q1 2025
$-0.01
Q2 2025
$0.00
Q3 2025
$0.07
Q4 2025
$0.01
Q1 2026
$-0.18
Q2 2026
Latest Revenue92.1M
Latest Net Income-31101000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.1892.1M-31101000+28.7%-1,700.0%
Q1 2026$0.0183.1M2.2M+38.3%+116.7%
Q4 2025$0.0785.8M11.1M+42.8%+333.3%
Q3 2025$0.0074.4M621.0K+37.1%+100.0%
Q2 2025-$0.0171.5M-1928000+48.8%+90.0%
Q1 2025-$0.0660.1M-9220000+47.9%+57.1%
Q4 2024-$0.0360.1M-5113000+35.4%+70.0%
Q3 2024-$0.1154.3M-15738000+12.3%-22.2%
Q2 2024-$0.1048.1M-15005000
Q1 2024-$0.1440.6M-18980000
Q4 2023-$0.1044.4M-13390000
Q3 2023-$0.0948.3M-12189000
Xeris Biopharma (XERS) — Earnings